2011 Fiscal Year Final Research Report
Development of a novel cellular vaccine of GITRL-Fc expressing tumor cells for treatment of patients with advanced malignancy
Project/Area Number |
21591664
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General surgery
|
Research Institution | Mie University |
Principal Investigator |
IKEDA Hiroaki 三重大学, 大学院・医学系研究科, 准教授 (40374673)
|
Co-Investigator(Kenkyū-buntansha) |
NISHIKAWA Hiroyoshi 大阪大学, 免疫学フロンティア研究センター, 准教授 (10444431)
|
Project Period (FY) |
2009 – 2011
|
Keywords | GITRL / GITRL-Fc / 抗腫瘍免疫 / T細胞マルチファンクション性 / 制御性T細胞 / T細胞移入療法 / 遺伝子療法 / siT+ AV3CRベクター |
Research Abstract |
Tumor cell vaccine expressing GITRL-Fc and gene therapy with adenovirus encoding GITRL-Fc were found to be effective in cancer immunotherapy. We started a clinical trial with TCR-gene modified T cells that express MAGE-A4-specific TCR for patients with advanced esophageal cancer. Stimulation through integrin molecules and CD4 T cell-help were found to enhance multifunctionality and survival of tumor specific CD8+ T cells.
|
Research Products
(38 results)
-
[Journal Article] T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/gc_null mice2012
Author(s)
Shirakura Y Mizuno Y, Wang L, Imai N, Amaike C, Sato E, Ito M, Nukaya I, Mineno J, Takesako K, Ikeda H, Shiku H
-
Journal Title
Cancer Sci
Volume: 103(1)
Pages: 17-25
Peer Reviewed
-
[Journal Article] Intracellular tumor-associated antigens represent effective targets for passive immunotherapy2012
Author(s)
Noguchi T, Kato T, Wang L, Maeda Y, Ikeda H, Sato E, Knuth A, Gnjatic S, Ritter G, Sakaguchi S, Old LJ, Shiku H, Nishikawa H
-
Journal Title
Cancer Res
Volume: 72(7)
Pages: 1672-1682
Peer Reviewed
-
-
-
-
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan(CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
Author(s)
Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
-
Journal Title
Vaccine
Volume: 7(49)
Pages: 6854-61
Peer Reviewed
-
-
-
-
-
-
[Presentation] Gene-Modified Lymphocytes : Harnessing T Cells for Effective Cancer Treatment. International Society for Cell Therapy2010
Author(s)
Ikeda H, Okamoto S, Mineno J, Imai N, Kageyama S, Ito M, Yasukawa M, Takesako K, Shiku H
Organizer
1^<st> Asia-Pacific Regional Meeting,招待講演
Place of Presentation
Miyazaki, Japan
Year and Date
20101017-20
-
[Presentation] Interaction with fibronectin fragment(RetroNectin) on TCR stimulation enhances proliferation and survival of human peripheral T cells2010
Author(s)
Hosoi H, Ikeda H, Hyuga C, Orito Y, Nukaya I, Enoki R, Mineno J, Takesako K, Kondo S, Shiku H
Organizer
CRI symposium 2010
Place of Presentation
NY, USA
Year and Date
20101006-08
-
-
-
-
-
-
-
-
-
-
[Presentation] A critical role for the multifunctionality of anti-tumor human T cells in TCR gene therapy evaluated in an in vivo model utilizing NOG mice2009
Author(s)
Mizuno Y, Ikeda H, Shirakura Y, Hiasa A, Hyuga C, Wang L, Imai N, Sato E, Ito M, Yu S, Mineno J, Kato I, Shiku H
Organizer
CRI symposium 2009
Place of Presentation
NY, USA
Year and Date
20090930-1002
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-